Should Parents Make Martyrs of Their Children?: An Argument for Private Regulation of Savior Siblings by Stoma, Samantha
Seton Hall University 
eRepository @ Seton Hall 
Law School Student Scholarship Seton Hall Law 
2021 
Should Parents Make Martyrs of Their Children?: An Argument for 
Private Regulation of Savior Siblings 
Samantha Stoma 
Follow this and additional works at: https://scholarship.shu.edu/student_scholarship 
 Part of the Law Commons 
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by Seton Hall University Libraries
 2
Should Parents Make Martyrs of Their Children?: An Argument for Private Regulation of 
Savior Siblings 
By: Samantha Stoma 
Introduction 
 In 1969, long before the rapid advancement of artificial reproductive technology, 
Kentucky courts considered whether Jerry Strunk, a 27-year-old legally incompetent individual 
with a mental age of approximately six years, could be compelled to donate a kidney to Tommy 
Strunk, Jerry’s 28-year-old brother who suffered from a fatal kidney disease.1 A majority of the 
Kentucky State Supreme Court deemed the transplant in the best interest of Jerry and allowed the 
kidney transplant to occur.2 Judge Steinfeld issued a vigorous dissent where he noted that he was 
torn between “a compassion to aid an ailing young man and a duty to fully protect unfortunate 
members of society.”3 Despite his apprehensions, Judge Steinfeld was unwilling to hold that an 
organ should be removed from an incompetent at the behest of the incompetent’s parents.4 The 
dissenter reasoned, “[p]arents may be free to become martyrs themselves. But it does not follow 
that they are free, in identical circumstances, to make martyrs of their children before they have 
reached the age of full and legal discretion when they can make that choice for themselves.”5 
 In Strunk, Judge Steinfeld contemplated the general ability of legal guardians to permit 
removal of an organ of their ward for the benefit of a third party. Judge Steinfeld’s moral 
dilemma would soon be amplified with the rapid advance of artificial reproductive technology. 
In 2000, genetic screening and in-vitro fertilization would allow a family in Colorado to select an 
 
1 Strunk v. Strunk, 445 S.W.2d 145 (Ky. 1969). 
2 Id. at 149. 
3 Id. (Steinfeld, J., dissenting). 
4 Id.  
5 Id.  
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embryo that was a perfect immunological match to donate body tissue to their ailing, already-
existing daughter with a blood disorder.6 That is, the Colorado family was able to use artificial 
reproductive technology to create a child specifically for the purposes of becoming a “martyr” 
for their already-existing child. This phenomenon became known as creating a “savior sibling.” 
 Judge Steinfeld contemplated how his sympathies for a sick young man weighed against 
his desire to protect society’s most vulnerable members.7 This delicate balancing also applies to 
cases involving savior siblings. On one hand, there is deep compassion and empathy for the sick 
sibling, who requires medical intervention to survive. On the other hand, there is an instinct to 
protect the “unfortunate” members of society – including the interests of the children who do not 
yet exist. The precarious balance between the need to procure treatment for a sick child and the 
welfares of a potential donor sibling must be bracketed by comprehensive regulation in order to 
assure that the best interests of all parties are met. 
 Part I of this paper will provide a primer on the reproductive technology used to create a 
savior sibling. With this background, Part II will consider the various ethical implications of 
using reproductive technology to create a child for the purpose of providing biological material 
to an older sibling. Part III will outline the regulatory approaches that some European nations 
have taken to prevent the potential ethical pitfalls associated with the procedure of savior 
siblings. These approaches are contrasted with the United states’ non-regulatory approach to the 
field of artificial reproductive technology inn Part IV. Finally, Part V proposes a solution that 
bypasses the difficulties associated with federal or state regulation which is private regulation led 
 
6 Josephine Marcotty, 'SAVIOR SIBLING' RAISES A DECADE OF QUESTIONS THE SEATTLE TIMES (2010), 
https://www.seattletimes.com/seattle-news/health/savior-sibling-raises-a-decade-of-questions/ (last visited Dec 16, 
2020). 
7 Strunk, 445 S.W.2d 149 (Steinfeld, J., dissenting). 
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by physician professional organizations. The proposal includes content suggestions for the 
guidelines promulgated by these organizations. 
 If Judge Steinfeld is correct in his reasoning that parents are not free to make martyrs of 
their children before the child has reached an age to make a legal choice for themselves, it 
follows that parents cannot be unbounded in their discretion to create a child for the specific 
purpose of becoming a martyr for their older sibling. 
Part I. Procedure Used to Create Savior Siblings 
A. Why do Families Need Savior Siblings? 
 The concept of savior siblings has been popularized in books and movies.8 However, the 
phenomenon of savior siblings is actually used worldwide to conceive and deliver a child who is 
a perfect Human Leukocyte Antigen (HLA) match to a sibling who is in need of a transplant to 
cure or treat an existing illness.9 In 2000, United States physicians were able to use IVF and 
PGD to conceive Adam Nash, a perfect HLA match for his older sister, Molly, who was born 
with Fanconi’s Anemia.10 Fanconi’s Anemia rendered Molly’s body unable to produce enough 
blood cells, and her only chance of survival was for the family to find a bone marrow donor.11 
The best bone marrow match is typically a sibling, but the Nash family understood that Molly’s 
condition was inherited so they were hesitant to have more children naturally.12 Eventually, the 
Nash family’s physicians were able to successfully perform PGD to conceive Adam, whose cord 
 
8 See MY SISTER'S KEEPER (New Line Cinema 2009).  
9 Donna M. Gitter, Am I My Brother’s Keeper? The Use Of Preimplantation Genetic Diagnosis To Create A Donor 
Of Transplantable Stem Cells For An Older Sibling Suffering From A Genetic Disorder, 13 GEO. MASON L. REV. 
975, 1016 (2006). 
10 Amanda M. Faison, THE MIRACLE OF MOLLY 5280 (2005), https://www.5280.com/2005/08/the-miracle-of-molly/ 




blood was used to cure Molly’s bone marrow failure.13 Although Molly’s condition is 
permanent, the birth of her brother saved her life.14 
 The Nash family exemplifies the typical case of why savior siblings are created. Usually, 
there is an already-existing life that is threatened by a blood-based illness. Without intervention 
in the form of blood transfusions or bone marrow transplant or cord blood transfusions or organ 
transplant, the already-existing child is going to die. Parents, unwilling to watch their child die, 
undertake to create a sibling who is not only free from disease, but also a perfect candidate to 
provide their sibling with life-saving treatment. While the Nash family only needed cord blood to 
save Molly’s life, it is necessary to consider what other body tissues may be required of savior 
siblings down the line. 
B. Technology Used to Create a Savior Sibling 
The term “savior sibling” is used to refer to a sibling created for the purpose of providing 
biological material that can help treat or cure an existing terminally ill child.15 Savior siblings are 
conceived using two consecutive artificial reproductive technology processes: (1) pre-
implantation genetic diagnosis (PGD) and (2) in-vitro fertilization (IVF).16 
 PGD is a multi-step process that involves ovarian stimulation, egg extraction, IVF, cell 
biopsy, genetic analysis, and embryo transfer.17 Clinicians first stimulate egg production in a 
woman, extract the eggs, and then fertilize the eggs with the desired sperm in a petri dish to form 




15 Zachary E. Shapiro, Savior Siblings in the United States: Ethical Conundrums, Legal and Regulatory Void, 24 
WAS. & LEE J. CIV. RTS. & SOC. JUST. 419, 422 (2018). 
16 Id. 
17 Baruch, et al., Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics, 89 
FERTILITY AND STERILITY 1053, 1054 (2008). 
18 Id. 
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analyzed.19 The genetic analysis of the embryonic cells is used to infer the genetic makeup of the 
egg.20 Typically, the desired (i.e., “healthy”) embryos that are disease-free and perfect 
immunological matches for their older sibling are implanted into a uterus or stored for future use, 
while the genetically-impaired (i.e., “sick”) embryos are destroyed.21 
 PGD is an artificial reproductive technology technique that was developed to detect and 
avoid specific disease-causing gene mutations before pregnancy.22 PGD is used to test embryos 
for diseases that are highly fatal within the first few years of life, such as Tay-Sachs disease, and 
for severely debilitating illnesses, such as cystic fibrosis.23 Today, the possible uses of PGD has 
been extended to include detection of genetic mutations leading to adult-onset disorders, such as 
Huntington’s disease, and the detection of mutations that indicate an increased risk of developing 
diseases later in life. Some couples elect to use PGD to select an embryo for the presence of a 
disability.24 In more controversial cases, PGD can be used to select the sex of an embryo, or a 
physical characteristic that satisfies the preferences of the future parents.25 
 In order to create a savior sibling, PGD is employed to both ensure that an embryo is free 
of the inheritable disease that plagues an older, already-existing child and ensure that the 
resulting child would be immunologically compatible to his or her older sibling in order to 
successfully donate life-saving bodily tissue.26 It is essential that the potential embryo is free 




21 Shapiro, supra note 15, at 422. 
22 Baruch, et al., supra note 17, at 1054. 
23 Id. 
24 Id. 
25 Id. at 1055. 
26 Baruch, et al., supra note 17, at 1055. 
27 Shapiro, supra note 15, at 425. 
 7
embryo chosen will develop into a child whose white blood cells contain the same HLA pattern 
as their older, ailing sibling.28 A donor must be an identical HLA match to the recipient in order 
to prevent the donated biological material from being rejected in the recipient sibling.29 If a 
donor is not an exact match, there is a risk that the recipient sibling’s immune system will reject 
the transplant, causing the transplant to fail and potential death in the recipient.30 By using PGD, 
clinicians can simply select healthy embryos who are perfect HLA matches to their older sibling. 
Part II. Ethical Issues of PGD and Savior Siblings 
 There are various ethical issues that arise when PGD is used to create a savior sibling for 
an already-existing ill child. The following discussion of such ethical considerations provides 
insight into the pitfalls that may occur when the process of creating savior siblings is entirely 
unregulated.  
A. Commodification of Donor-Sibling 
First, there is a persistent worry that the savior siblings would be used as a commodity 
rather than a person.31 In other words, there is a concern that a child created for a specific 
purpose would be treated as a means rather than an end. Lord Robert Winston, one of the fertility 
experts who helped to develop the PGD technique, frequently criticizes the use of PGD in order 
to create a savior sibling because of the risk of treating the offspring to be born as a 
commodity.32 Lord Winston argues that using PGD to create a savior sibling might prevent the 





31 Amy T. Lai, To Be or Not to Be My Sister’s Keeper? A Revised Legal Framework Safeguarding Savior Siblings’ 
Welfare, 32 J. LEGAL MED. 261, 265 (2011). 
32 Gitter, supra note 9, at 1016. 
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sibling.33 Other commentators argue that the commodification ethical argument necessarily fails 
if parents intend to care for the new child for its own sake.34 These scholars argue that the 
resulting child will not be commodified because the fact that parents are willing to conceive 
another child in order to protect the first child suggests that these parents are highly committed to 
the well-being of their children, thereby suggesting that these parents will value the savior 
sibling for its own sake as well.35  
B. Inability of Minor Child to Consent  
Related to the commodification concern is the argument that even if the donor-sibling is 
valued as a child independent of their ability to donate biological material, the minor might face 
intense familial pressure to serve as a continuing source of donations to the ill sibling.36 A major 
part of the donor-sibling’s identity might be intimately tied to his ability to donate biological 
material to his sibling. The worry that the donor child might see himself as a commodity raises 
serious issues about the minor child’s ability to consent to donation. 
From the perspective of the savior sibling, autonomy is further threatened because of the 
child’s inability to provide consent to medical procedures.37 For very young children, the critical 
element of competence is lacking.38 The lack of competence in young children is concerning 
because they are generally unable to signify to medical professionals that they have the ability to 
make health-related decisions.39 Additionally, it is doubtful that a young child can be informed 
 
33 Id. 
34 Lai, supra note 31. 
35 Gitter, supra note 9, at 1017. 
36 Id. at 1019. 
37 Giovanni Rubeis & Florian Steger, Saving whom? The ethical challenges of harvesting tissue from savior siblings, 




about the nature, scope, and consequences of a medical procedure in an appropriate way.40 
Compounded with the possible pressure from family to provide needed body tissue to a sick 
sibling, the autonomy of a donor-sibling is severely threatened by the young child’s inability to 
provide informed consent to medical providers. 
C. Psychological Effects on Donor-Sibling 
Another ethical concern associated with the use of PGD to create savior siblings is the 
potential negative psychological effects on the donor child.41 There is little empirical evidence 
regarding the psychological welfare of a PGD-created donor-sibling, but the fear is that the 
donor child might suffer from a lack of self-confidence because the child believes her parents 
created her only to help provide treatments for older sibling.42 The child may believe he would 
not have been born had it not been for her sibling’s disease.43 Perhaps more concerning would be 
the burden felt by a donor-sibling if the treatments using the donor-sibling’s biological material 
fail and the sick sibling passes away.44 Some scholars point out that there might be positive 
psychological benefits to a donor-sibling. Namely, the knowledge that the donor-sibling’s birth 
saved the life of a sibling may be empowering and bolster the donor-sibling’s sense of self-
worth.45  
D. Physical Effects on Donor-Sibling 
There is also an ethical concern surrounding the potential physical effects on the donor 
child.46 The PGD procedure involves removing cells from an embryo which may cause injury to 
 
40 Id. 
41 Gitter, supra note 9, at 1022. 
42 Sandra O. Samardžić, Saviour Siblings – Current Overview, Dilemmas and Possible Solutions?, 12 MED. L. & 
SOC. 89, 100 (2019). 
43 Id. at 99. 
44 S. Sheldon & S. Wilkinson, Should selecting saviour siblings be banned?, 30 J. MED. ETHICS 533, 535 (2004).  
45 Samardžić, supra note 42, at 101.  
46 Id. at 99. 
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the embryo.47 Importantly, there have been no studies conducted to determine the long-term 
effects that PGD has on the health of children.48 Possible impacts on the physical health of a 
donor-sibling involving the actual donation of biological material could include injury from 
multiple procedures and the typical risks associated with organ donation, including potential 
death, if the ailing sibling requires an organ.49 Organ donation is a more extreme example of how 
a donor-sibling may serve their sick sibling. Typically, the donor-sibling is asked to donate blood 
or bone marrow, especially if harvesting stem cells from the umbilical cord was unsuccessful.50 
Harvesting stem cells from the donor-sibling’s umbilical cord poses no risk to the donor-
sibling.51 Harvesting bone marrow from a child involves surgery, which poses the typical risks 
associated with general anesthesia and the risks of bleeding and infection.52 
E. Non-Medical Uses of PGD  
A general concern with the unregulated procedure of PGD is the potential for a “slippery 
slope.” The concern is that PGD, when unregulated, will be used for eugenic practices of 
creating an “ideal” child.53 With economic gain in mind, clinics may formulate policies that 
encourage couples seeking certain physical characteristics for their offspring to receive PGD 
services with their clinicians.54 With the current, non-regulatory state of artificial reproductive 
technology clinics in America, clinics have unchecked power to market and provide couples with 
 
47 Id. at 99. Samardžić cites a study done on mice subjected to PGD in the embryonic phase that revealed the 
resulting mice experienced excess weight and memory problems later in life. 
48 Id. 
49 Id. 
50 Samardžić, supra note 42, at 100. 
51 Id. 
52 Indranil Mallick, A LOOK AT THE DIFFERENT RISKS AND SIDE EFFECTS OF DONATING BONE MARROW, Verywell 
Health (2019), https://www.verywellhealth.com/the-risks-of-donating-bone-marrow-2252482 (last visited Dec 16, 
2020).  
53 Gitter, supra note 9, at 1024. 
54 Id. 
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babies designed pursuant to the couple’s preferences rather than to ensure the health of the 
resulting fetus.55  
Part III. Regulatory Schemes Abroad 
 In order to comprehensively address the ethical concerns associated with PGD and savior 
siblings, many countries have decided to outline the boundaries of acceptable uses of PGD 
through comprehensive, national regulation. On other hand, some countries, including the United 
States, have decided to take an entirely hands-off approach to the field of artificial reproductive 
technology and PGD. Non-regulatory states provide clinicians with unbounded authority to 
determine when PGD is warranted. Part III discusses the regulatory schemes found in three 
European countries: France, the United Kingdom, and Spain. Part IV will discuss the non-
regulatory approach of the United States. 
A. France 
 France has a detailed regulatory framework for PGD.56 The French government explicitly 
sanctions the use of PGD in the Code de la Santé Publique only in exceptional cases.57 Initially, a 
doctor in a prenatal clinic must “certify that the couple, because of their family situation, has a 
high probability of giving birth to a child with a genetic disease of particular gravity recognized 
as incurable at the time of diagnosis.”58 A doctor needs certain evidence to certify a couple for 
PGD.59 If the couple already has a child with a severe heritable illness or an immediate relative 
 
55 Id. 
56 Michelle J. Bayefsky, Comparative preimplantation genetic diagnosis policy in Europe and the USA and its 
implications for reproductive tourism, 3 REPRODUCTIVE BIOMEDICINE AND SOC. ONLINE 41, 43 (2016) [hereinafter 
Comparative PGD Policy]. 




of either individual has a severe heritable illness, these facts can serve as evidence that a couple 
is qualified to receive PGD.60  
 In France, the Agence de la Biomedicine is the government organization that dictates the 
acceptable standards of prenatal clinics as well as the necessary qualifications of providers who 
can perform PGD.61 The Agence de la Biomedicine also espouses the acceptable uses of PGD 
that authorized PGD clinics in France are bound to follow.62 In 2012, the Agence de la 
Biomedicine endorsed that PGD should be used to select potential donors for sick siblings.63 
Therefore, a French individual seeking to receive PGD for the purpose of creating a savior 
sibling is legally permitted to do so, if the individual is initially deemed to be at sufficient risk of 
having a child with an incurable heritable disease. Once that medical determination is made, then 
then individual can consent to PGD for the purpose of creating a savior sibling. 
B. United Kingdom 
 In the United Kingdom, Parliament regulates PGD through the Human Fertilization and 
Embryology Act (the Act) of 1990.64 Pursuant to the Act, the Human Fertilization and 
Embryology Authority (HFEA) is the government organization that was created to:  
(a) keep under review information about embryos and about the 
provision of treatment services and activities governed by this 
Act…(b) publicise the services provided to the public by the 
Authority or provided in pursuance of licenses, (c) provide, to such 
extent as it considers appropriate, advice and information for 
persons to whom licenses apply or who are receiving treatment 
services or providing gametes or embryos for use for the purposes 
of activities governed by the act or may wish to do so.65 
 
 
60 Public Health Code, art. L2131-4-1 (Fr.). 
61 Michelle J. Bayefksy, Who Should Regulate Preimplantation Genetic Diagnosis in the United States?, 20 AMA J. 
OF ETHICS 1160, 1161 (2018) [hereinafter Who Should Regulate PGD?]. 
62 Id. 
63 Id. 
64 Human Fertilisation and Embryology Act 1990 c. 37 (Eng.). 
65 Id. at §8. 
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 The HFEA continues to be the primary government licensing agency for clinics in the 
United Kingdom that carry out IVF and donor insemination.66 In R (on the application of 
Quintavalle) v. Human Fertilisation and Embryology Authority, the House of Lords decreed, 
“[the Act] clearly gave the HFEA the authority to honor a family’s request for PGD with tissue 
typing if the HFEA found it proper, as well as to decline such a license on ethical or other 
grounds.”67 The court’s holding underscores the broad authority given to the HFEA to determine 
whether PGD to create a savior sibling is appropriate. 
 In response to Quintavalle, Parliament amended the Act in 2008 to sanction the use of 
PGD with HLA-matching to create a savior sibling within certain regulatory boundaries.68 The 
2008 amendments to the Act specified: 
A license…cannot authorize the testing of an embryo, except for one 
or more of the following purposes…(d) in a case where a person 
(‘the sibling’) who is the child of the persons whose gametes are 
used to bring about the creation of the embryo (or of either of those 
persons) suffers from a serious medical condition which could be 
treated by umbilical cord blood stem cells, bone marrow or other 
tissue of any resulting child, establishing whether the tissue of any 
resulting child would be compatible with that of the sibling.69 
 
 The HFEA requires clinics to obtain licenses for every new genetic disease that they 
would like to test an embryo for using PGD.70 By closely monitoring the uses of PGD, the HFEA 
is able to prevent the slippery slope of allowing PGD to be used for non-medical purposes or sex 
selection. The Act attaches criminal liability to a person who “provides any information for the 
purposes of the grant of a license, being information, which is false or misleading in a material 
 
66 Gitter, supra note 9, at 980. 
67 R (on the application of Quintavalle) v. Human Fertilisation and Embryology Auth., [2005] UKHL 28 (House of 
Lords 2005). 
68 Lisa Cherkassky, The Wrong Harvest: The Law on Saviour Siblings, 29 INT J. L., POL’Y, & FAM., 1, 4 (2020). 
69 Human Fertilisation and Embryology Act 1990 c. 37, sch. 2 (Eng.). 
70 Shapiro, supra note 15, at 451. 
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particular and, either he knows the information to be false or misleading in a material particular 
or he provides the information recklessly….”71 Individuals who provide false or misleading 
information to obtain a license in violation of the Act are subject to a fine and/or imprisonment 
for up to two years.72 
C. Spain 
 Spanish legislators regulate the use of artificial reproductive technology through the Ley 
de Técnicas de Reproducción Humana Asistada.73 On the topic of PGD, the Assisted 
Reproduction Procedures Law states: 
Duly authorized centers may practice preimplantation diagnostic 
techniques for: (a) the detection of serious hereditary diseases, of 
early appearance and not susceptible to post-natal curative treatment 
according to current scientific knowledge, with the purpose of 
carrying out the embryonic selection of the pre-embryos not affected 
for their transfer; (b) the detection of other alterations that may 
compromise the viability of the pre-embryo. The application of pre-
implantation diagnostic techniques in these cases must be 
communicated to the corresponding health authority, which will 
inform the National Commission of Assisted Human Reproduction 
[CNHRA]. The application of pre-implantation diagnostic 
techniques for any other purpose not included in the previous 
section, or when they are intended to be practiced in combination 
with the determination of the histocompatibility antigens of the in 
vitro pre-embryos for therapeutic purposes for third parties, shall 
require the express authorization, case by case, of the corresponding 
health authority, after a favorable report from the CNHRA, which 
shall evaluate the clinical, therapeutic and social characteristics of 
each case.74 
 
Unlike France and the United Kingdom, Spanish individuals wishing to use PGD for the 
purpose of “histocompatibility antigens…for therapeutic purposes for third parties” (i.e., for 
 
71 Human Fertilisation and Embryology Act 1990 c. 37, §41 (Eng.). 
72 Shapiro, supra note 15, at 451. 
73 Ley 14/2006, de 26 de mayo, sobre técnicas de reproduction humana asistada [Assisted Reproduction Procedures 
Law] (B.O.E. 2006, 126) (Spain). 
74 Assisted Reproduction Procedures Law art. XII (B.O.E. 2006, 126) (emphasis added). 
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savior siblings), are required to undergo individual evaluation by the corresponding health 
authority and receive a favorable report from the appropriate governing body, the CNHRA. Only 
after the authorities review the clinical, therapeutic, and social characteristics of a particular case 
will the individual be allowed to proceed with the PGD procedure.75 In France and the United 
Kingdom, by contrast, the governing bodies exercised regulatory authority to sanction the uses of 
PGD for the purpose of creating a savior sibling if a clinic or individual meets certain criteria.76 
Individuals in the United Kingdom and France seeking to create savior siblings are not required 
to undergo vigorous case analysis as is required in Spain. 
Part IV. Current Regulatory Scheme in the United States 
 The United States has taken a hands-off approach to federal regulation of artificial 
reproductive technology. The regulatory lacuna on the federal level forces states to fill in the 
blanks and regulate providers and clinics specializing in artificial reproductive technology. States 
may be in the best position to consider the specific needs and values of citizens of the state, but – 
like the federal government – states have largely refused to draft legislation regarding artificial 
reproductive technology. Because states have also neglected specific regulations regarding 
artificial reproductive technology, conflicts involving artificial reproductive technology care 
have, by default, fallen into the lap of the state judiciary. Part IV explores the current, non-
regulatory framework of the United States and how conflict regarding artificial reproductive 
technology, and specifically PGD, is resolved. 
A. Lack of Federal Regulation 
 
75 Samardžić, supra note 42, at 93. 
76 See supra Part III.A-B. 
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 In the United States, there are no federal laws on the acceptable use of PGD.77 Since the 
process of creating savior siblings can only be accomplished through PGD, it follows that no 
governmental oversight or legal guidance regarding the use of savior siblings exists.78 The 
analytical quality of the tests and the qualifications of the personnel performing the tests are 
subject to the Clinical Laboratory Improvement Amendments (CLIA) of 1988.79 The CLIA 
requirements include standards and testing to monitor laboratory performance.80 The Center for 
Medicare and Medicaid Services (CMS), the federal agency that administers CLIA, has refused 
to establish specific proficiency testing regulations for molecular genetic testing, including the 
genetic analysis of preimplantation embryos.81 Likewise, the Food and Drug Administration 
(FDA), which generally regulates genetic tests for analytical and clinical validity, does not 
espouse specific guidance regarding PGD or savior siblings.82 
B. State Judicial Response 
The regulatory gap on the federal level leaves the topic of PGD and savior siblings open 
to state and private regulation. The parens patriae power of states grants “inherent power and 
authority of the state to protect persons who are legally unable to act on their own behalf.”83 
While there are strong constitutional protections to safeguard a parent’s right to rear his children 
according to the parent’s wishes, a state can circumvent these rights by asserting its parens 
patriae power to protect children from harm.84 A state is therefore empowered to intervene if the 
 
77 Comparative PGD Policy, supra note 56, at 43. 
78 Shapiro, supra note 15, at 444. 
79 Id. at 445. 
80 Baruch, et al., supra note 17, at 1056. 
81 Shapiro, supra note 15, at 444. 
82 Id. 
83 Legal Dictionary, PARENS PATRIAE, https://legal-dictionary.thefreedictionary.com/parens+patriae (last visited 
Nov. 1, 2020). 
84  Marley McClean, Children’s Anatomy v. Children’s Autonomy: A Precarious Balancing Act with 
Preimplantation Genetic Diagnosis and the Creation of “Savior Siblings,” 43 PEPP. L. REV. 837, 851 (2016). 
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state “believes the child is either endangered or not receiving adequate parental care because of 
the child’s use as a savior sibling. The state can also protect a child born as a result of PGD by 
requiring informed consent for medical procedures….”85 
No state laws have been enacted specifying regulations for PGD or savior siblings.86 There is a 
small amount of case law on the state level that illustrates the state responses to issues of whether 
donation from a minor sibling is in the best interests of both minor siblings.87 Importantly, this 
case law helps courts determine whether tissue or organ donation between minors is acceptable.88 
There is, however, no case law regarding the propriety of the savior sibling procedure. 
The case law analyzing tissue or organ donation between a minor donor and a minor 
recipient reveals two governing legal standards: (1) the best interest standard and (2) the 
substituted judgment standard.89 The best interests standard instructs courts to determine 
“whether allowing a child to donate tissue or organs would be in the best interest of the child and 
the child’s needs.”90 In the context of sibling donations, courts will often look to the relationship 
of the siblings to determine if the siblings have a close relationship.91 If the siblings have a close 
relationship, courts are likely to conclude that donor sibling would be psychologically benefited 
if his or her sick sibling survives because of the donation.92 
In Curran v. Bosze, the Supreme Court of Illinois iterated that a transplant would be 
considered in the child-donor’s best interest if: 
 
85 Id. 
86 Shapiro, supra note 15, at 444. 
87 McClean, supra at note 84, at 852. 
88 Id. 
89 Id. 
90 Id. at 853. 
91 Nicole Hebert, Note, Creating A Life To Save A Life: An Issue Inadequately Addressed By The Current Legal 
Framework Under Which Minors Are Permitted To Donate Tissue And Organs, 17 S. CAL. INTERDISC. L. J. 337, 356 
(2008). 
92 Id.  
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(1) the parent or guardian who consented on behalf of the minor was 
well informed of the risks and benefits to the child-donor inherent 
in the medical procedure; (2) the parent or guardian would be able 
to provide adequate emotional support to the donor; and (3) there 
was an existing, close relationship between the donor and 
recipient.93  
 
Illinois’s highest court considered how to apply the standard in the context of a father 
who petitioned the court to compel his three-year-old twin girls to undergo compatible blood 
testing and potentially donate bone marrow to their half-sibling.94 The twins’ mother, who is not 
the mother of the ailing child and was never married to the twins’ father, refused the 
compatibility testing for her daughters.95 Under the standard announced by the court, the state 
supreme court determined that it was not in the best interest of three -year-old twins to compel 
compatibility testing to potentially serve as bone marrow donors for their half-brother whom 
they had only met twice because the donor-recipient relationship was not sufficiently close.96 
The other legal standard used to determine the legality of organ or tissue donation from a 
minor is the substituted judgment standard.97 The substituted judgment standard requires courts 
to essentially place themselves in the position of the minor to determine whether the minor 
patient would choose or refuse to make an organ or tissue donation if she were fully competent 
to make the decision on her own.98 The historical use of the substituted judgment standard 
requires “clear and convincing evidence of the patient’s intent, derived either from a patient’s 
explicit expressions of intent or from knowledge of the patient’s personal value system” in order 
for a primary caregiver to substitute what he believes would be the incompetent patient’s 
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decision regarding medical treatment.99 The standard has largely been used for people who were 
once legally competent, but became incompetent.100 The application of the substituted judgment 
standard to potential minor donors has been criticized on the ground that a child has never been 
legally competent so there is no “clear and convincing evidence” regarding what the minor’s 
intent would be for a critical medical decision.101 
When applying the substituted judgment standard, courts have disregarded the analysis of 
whether the minor child would wish to donate tissue or organs if the child were competent.102 In 
Hart v. Brown, the court purported to use the substituted judgment standard to determine whether 
a seven-and-a-half year old child could be permitted to donate a kidney to her identical twin 
sister.103 In Hart, the parents of identical twin girls brought suit against physicians treating one of 
their daughters with a terminal kidney illness.104 The physicians refused to allow the parents to 
provide consent for their healthy child to undergo a kidney transplant for the benefit of her twin 
sister, so the parents filed action in state court to compel the physicians to allow for the parents’ 
consent on behalf of the healthy child.105 The court concluded that, under these facts, the 
potential donor sibling had a strong identification with her twin sister and therefore the donation 
would be most beneficial to the donee and would be of some benefit to the donor.106 The court 
held that prohibiting the natural parents of the minor child the right to give consent in situations 
where there is supervision by the court and other persons in examining their judgment, would be 
“unjust, inequitable, and injudicious.”107 Although purporting to apply the substituted judgment 
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standard, the Hart court concluded that the transplant was permissible based on an analysis more 
akin to the best interests standard.108 
As more children are conceived using PGD for the purpose of donation for an older, sick 
sibling, state courts may need to grapple with the deficiencies of the current standards governing 
the legality of organ and tissue donation by minor children. Statutory mandates would provide 
the necessary standards for courts to enforce when facing issues that arise when a child is created 
solely for tissue and organ donation. However, these statutory mandates are unlikely to be 
enacted by state or federal regulation because of several challenges unique to the United States 
medical system.  
C. Challenges in the United States to Federal or State Regulation of PGD 
There are several obstacles preventing the comprehensive regulation of PGD and savior 
siblings in the United States. The most significant barrier is the United States’ lack of 
government-sponsored healthcare. Unlike the United Kingdom, France, and Spain, in the United 
States, most citizens are covered by private insurance.109 Some United States citizens qualify for 
government-sponsored healthcare programs like Medicare, Medicaid, and the Veterans Health 
Administration. However, none of these government-sponsored programs cover advanced 
fertility treatments like IVF and PGD.110 Lack of a healthcare system largely or entirely 
subsidized by the government encourages a deregulatory state because the United States, by 
virtue of a privatized healthcare system, is not compelled to stipulate when artificial reproductive 
technology like PGD is permissible.111  
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Unlike countries with government-sponsored healthcare, it is not necessary or inevitable 
for the United States to regulate medical practice.112 In addition to a lack of urgency, the United 
States government is dissuaded from regulation of artificial reproductive technology and PGD by 
various interest groups.  
First, physician trade groups are likely to see any regulatory body arising from the 
government as a “significant and unprecedent intrusion into private medical practice.”113 Private 
practitioners believe that because the government does not provide any funding, the government 
lacks the power to regulate their medical practice.114  
Second, interest groups within the right-to-life and pro-choice movements have created a 
divisive backdrop for embryo politics in the United States. Fertility treatment often involves 
discarding excess embryos, and the legal rights of the destroyed embryo are hotly contested.115 
This highly polarizing political issue has resulted in the federal government distancing itself 
from the issue at large.116 Legislation regarding PGD and savior siblings would involve the 
United States government to stake a position on the controversies of embryo politics. In order to 
safeguard political interests, legislators have consistently refused to implement policies regarding 
the whole field of artificial reproductive technology, including PGD and savior siblings.117  
Lastly, disability rights advocacy groups frequently argue that PGD will cause increased 
injustice, stigmatization, and discrimination against people with disabilities.118 This argument is 
grounded in the theory that PGD will be “misused by putting pressure on people to select against 
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embryos that do not have a severe genetic disease.”119 This pressure might alter the narrative 
surrounding disabilities and bolster injustice, stigma, and discrimination against disabled 
people.120 Some commentators suggest that certain government regulations may send a message 
to the disabled community that legislators have collectively decided that they do not value people 
living with disabilities to the extent of “normal” people.121 It is not clear to what extent these 
groups have had an impact on the United States government’s “hands-off” approach to 
regulation of PGD. 
D. Consequences of Lack of Governmental Regulation 
Certain dangers arise out of the government’s persistent refusal to regulate PGD in the 
context of savior siblings. First, there are no formal mechanisms in place to ensure that the best 
interests of a donor sibling are able to be met. Clinics performing PGD with the goal of creating 
savior siblings have an unchecked power to make their own decisions about what is best morally 
and ethically for their patients.122 Second, because clinics are not operating under a standardized 
mandate regarding the limits on the savior sibling procedure, similarly situated individuals may 
have vastly different options available to them depending on the individual policies of the clinics 
performing PGD in their area.123 Third, the lack of any centralized funding restricts data-
gathering and information regarding use and prevalence of savior siblings.124 Barriers to 
comprehensive data collection lead to difficulties in monitoring the long-term outcomes for 
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savior siblings, ensuring that the children are being respected and cared for, and ensuring that the 
children do not face lifetime burdens because of their status or biology.125 
As discussed, there are significant sociocultural obstacles to comprehensive government 
regulation of PGD in the United States. Despite the potentially harmful consequences of non-
regulation, the United States government has consistently refused to stake a position on the field 
of artificial reproductive technology. This leaves little hope for any near-future regulation 
regarding the welfare of children involved in the savior sibling process. 
E. Professional Self-Regulation of PGD 
 Professional societies and private advocacy groups are the only groups drafting American 
policy addressing artificial reproductive technology.126 Of the groups addressing artificial 
reproductive technology as a whole, only a handful have addressed PGD directly. The American 
Society for Reproductive Medicine (ASRM) has issued guidelines for laboratory conditions and 
accreditation of clinics performing PGD.127 The ASRM Ethics Committee has also issued 
positions on PGD screening procedures related to sex selection.128 Other private advocacy 
groups, including the PGD International Society (PGDIS) have issued practice guidelines for 
PGD.129 The ASRM and other professional groups like the American College of Obstetricians 
and Gynecologists (ACOF) lobby Congress extensively for broader insurance coverage, minimal 
government regulation of artificial reproductive technology, and maximum access for patients 
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seeking treatment for infertility.130 Traditionally, physicians follow the guidelines promulgated 
by professional organizations to the maximum extent due to state licensing and malpractice 
concerns.131 While the procedural guidelines may be somewhat set by professional organizations 
through self-regulation, substantive decisions regarding the ethical acceptability of certain 
practices largely fall within the physician’s own medical judgment.132 
V. Proposal 
Because of the potential dangers that arise when the process of savior siblings is 
unregulated, Part V proposes a solution that avoids the barriers associated with government 
regulation and serves as a first step toward comprehensive regulation ensuring the welfare of 
savior siblings and families. Physician professional organizations should consider promulgating 
guidelines that outline the acceptable uses of PGD, including guidelines for creating a savior 
sibling. I offer that a specific physician-led group can be created using the models of the HFEA 
in the United Kingdom, the Agence in France, and the CNHRA in Spain. The guidelines that the 
physician groups promulgate should encompass a “best-interests” approach to ensure the welfare 
of all children involved and the consent of the minor child to determine when tissue donation 
from a savior sibling is appropriate. 
A. Physician Professional Organizations 
 The significant barriers to comprehensive federal regulation make private regulation 
through physician professional organizations the most viable option for regulation of PGD and 
savior siblings. Historically, the United States government has left the regulation of medical 
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practice to the states.133 While no states have enacted laws pertaining to PGD, a state-by-state 
regulation mosaic would be undesirable.134  
Divergent laws among states will create a type of reproductive tourism intra-nationally. 
Individuals who live in states with harsher laws regarding PGD and savior siblings may travel 
within the country to find a clinic in a state with more relaxed laws. Reproductive tourism can 
pose certain health risks to patients and the resulting offspring.135 Patients who travelled a great 
distance may feel pressure to transfer multiple embryos at once, which leads to greater risks of 
morbidity and mortality associated with pregnancy of multiples.136 Additionally, clinics in the 
patient’s home state may be reluctant to treat patients who become pregnant abroad as a result of 
prohibited treatment, making it difficult to perform monitoring and follow-up after IVF and PGD 
to ensure a healthy pregnancy and live birth.137 Lastly, patients may fear legal or social backlash 
in their home state and feel pressured to withhold certain medical information about their child’s 
conception.138 The cost of travel and out-of-pocket expenses for the procedure may also foster 
inequalities in access to PGD and savior siblings.139 Because of the significant medical and 
social challenges, state-by-state regulation of PGD and savior siblings is currently undesirable. 
Federal and state regulation alike are impracticable. Private regulation through physician-
led organizations is therefore preferable. It is clear that physicians and primary care providers are 
in the best position to balance the needs of their patients against the larger, ethical backdrop of 
PGD and savior siblings. These health professionals are often the most familiar with patients and 
the most equipped to ask the necessary questions to determine the bona fide intent of their 
 
133 Who Should Regulate PGD?, supra note 61, at 1163. 
134 Id. 
135 Comparative PGD Policy, supra note 56, at 45. 
136 Id. 
137 Id. 
138 Id.  
139 Id. 
 26 
patients.140 Similarly, as health professionals are necessary to the PGD process, they are in the 
best position to consider the individual considerations of a certain patient’s case with the 
limitations of PGD, genetic testing, and the possibility of new medical developments.141 
There are certain limitations to professional self-regulation of PGD. First, allowing 
medical professionals to determine the breadth of allowable PGD use may induce clinicians to 
promulgate overly broad rules and guidelines in their own self-interest or bias.142 To mitigate this 
risk, there should be multiple stakeholders, including patient advocacy groups, involved in the 
promulgation of guidelines.  
Another limitation to relying on professional organizations to govern the uses of PGD 
and savior siblings would be that these guidelines would not be as enforceable as a state or 
federal mandate.143 However, while self-imposed professional guidelines are not legally binding, 
they often make up the baseline “standard of care” required when treating a patient.144 Physicians 
that fail to follow the standard of care set by the industry often experience scrutiny from peers 
and patients, are vulnerable to litigation, and may be at risk for losing their professional 
licenses.145 From a business perspective, physicians who fail to follow professional guidelines 
may also face severe scrutiny from potential patients, who may decide to take their healthcare 
needs to a more professional medical facility. 
There are several already-existing physician professional groups who could take on the 
role of promulgating guidelines regarding the use of PGD and savior siblings. These 
organizations include the ASRM, ACOG, the American College of Medical Genetics and 
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Genomics, and others.146 The ASRM is particularly fit to promulgate guidelines regarding the 
use of PGD for savior siblings because it already has an ethics committee and various 
subcommittees that issue opinions and guidance to clinics performing artificial reproductive 
techniques. Further, the ASRM is a “multidisciplinary organization dedicated to the 
advancement of the science and practice of reproductive medicine.”147 Basic and clinical 
scientists, nurses, technologists, mental health care associates, practice managers, OB/GYNs, 
urologists, psychiatrists, and psychologists are all included in ASRM’s membership.148  
The ASRM has promulgated guidelines that encompass a range of clinical practice and 
ethical issues.149 However, the ASRM has only issued guidelines addressing the use of PGD for 
sex selection, but not the use of PGD for HLA-matching.150 The ASRM is therefore sitting on a 
wealth of first-hand knowledge of PGD  (and, perhaps, some knowledge of PGD for the use of 
savior siblings) but has thus far failed to address the ethical implications and provide guidelines. 
While ASRM does issue these lengthy guidelines to members including fertility clinics and 
sperm banks, it does not sanction those who are in violation of guidelines.151 Other professional 
organizations, like the American Medical Association (AMA), direct individuals to file 
grievances against a medical professional with their state’s medical licensing board if the 
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individual believes a medical professional or facility is acting unethically or failing to provide a 
certain standard of care.152 
I maintain that the ASRM is a viable option to promulgate guidelines for United States 
clinics to use regarding PGD and savior siblings. The ASRM is sufficiently analogous a weaker, 
“private” version of the United Kingdom’s HFEA, France’s Agence de la Biomedicine, and 
Spain’s CRHNA. The similarities between the ASRM, the HFEA, the Agence, and the CRNHA 
demonstrate that the ASRM can serve as a functioning regulatory body, even if it operates 
outside of the United States government. Additionally, the ASRM can adopt certain procedures 
from the French, English, and Spanish models to emulate the comprehensive regulatory schemes 
found in the European Union.  
B. Models in the European Union 
The French Agence de la Biomedicine oversees PGD by announcing appropriate uses of 
the procedure.153 Clinics are then responsible for following the Public Health Code to ensure that 
an individual seeking PGD meets certain criteria and the individual is utilizing PGD for purposes 
sanctioned by the Agence de la Biomedicine.154 While there is no legislative equivalent to the 
Public Health Code regarding artificial reproductive technology in the United States, a private 
organization like the ASRM can absorb the responsibilities of the Agence de la Biomedicine and 
agree to promulgate guidelines regarding the appropriate uses of PGD, including the boundaries 
of using PGD to create savior siblings. Further, the ASRM could direct clinics to consider 
individual candidates for PGD within a certain set of criteria. These criteria do not have to be 
binding for the individual to receive the procedure (like it is in France) but it could orient clinics 
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towards the best candidates for PGD and avoid ethical pitfalls. For example, the ASRM can 
direct clinics to accept only candidates seeking PGD for a medical purpose, and reject candidates 
seeking PGD for sex selection. There would be no complementary enforcement mechanisms, as 
there are in France, but the guidelines will assert pressure over ASRM membership to conform to 
the professional standard of care.  
 The ASRM, or a similar professional organization, might also look to the United 
Kingdom’s HFEA for guidance regarding how to enact recommendations regarding the use of 
the PGD procedure to create savior siblings. In a similar manner to the French Agence de la 
Biomedicine, the HFEA issues binding guidance regarding the appropriate uses of PGD.155 The 
HFEA, pursuant to its broad authority granted by the Human Fertilization and Embryology Acts, 
requires clinics to obtain licenses for every new genetic disease that they would like to test an 
embryo for using PGD.156 Once the clinic is granted a license for a specific procedure, they are 
permitted to perform the procedure within limitations provided by law.157  
The UK model would work well for an organization like the ASRM because the 
multidisciplinary membership of the ASRM is ideal to lay out acceptable uses and limitations of 
using the procedure to create savior siblings. With an organization like ASRM, every stakeholder 
can be represented in the discussions regarding best practices of using PGD to create savior 
siblings. The ASRM does not have the authority to issue licenses, as the HFEA does, but it is 
possible that the state-based professional licensing agency would adopt the ASRM’s 
recommendations as mandatory requirements for clinics to follow as a prerequisite to become 
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licensed to perform PGD in the state.158 Further, the ASRM can offer certain accreditations that 
bolster a clinic’s credibility, even if they are not necessary. 
Spain’s system of review for determining when PGD is appropriate to create a savior 
sibling may be too rigorous to be duly applied in the United States. In Spain, clinics and 
independent groups must evaluate individuals seeking to use PGD to create savior siblings on a 
case-by-case basis.159 The governing body, the CNHRA, must then issue a favorable report.160 
The sheer administrative burden would probably be sufficient to conclude that this system would 
not work in the United States. Additionally, the notions of autonomy and privacy among 
American individuals and medical professionals may be offended if individuals seeking a certain 
procedure are required to undergo vigorous analysis before the procedure.  
For these reasons, broad guidelines for clinicians to follow that are similar to the 
regulatory system in the United Kingdom and France would be ideal as they would not hamper 
reproductive rights. If an individual believes that they were wrongfully rejected for the procedure 
under the guidelines promulgated by the ASRM, they have recourse in the state court system. A 
family can also seek recourse in state courts if they believe a clinic is wrongfully refusing to 
follow the professional standard of care as laid out by physician-led organizations. Therefore, 
guidelines from professional physician organizations combined with the availability of judicial 
review can provide robust protections for families seeking to utilize PGD for the purpose of 
creating a savior sibling. These processes can also provide robust protection for the interest of 
the potential donor child.  
C. Best-Interests of the Child  
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 The best-interests standard should be incorporated into the ASRM’s guidelines regarding 
when clinics should perform PGD in order to create savior siblings. The proposal does not 
endorse assigning judicial functions to private bodies. Instead, the best-interests standard should 
be folded into the general guidelines promulgated by private organizations for medical 
professionals to follow. In other words, private organizations will not be judging individuals 
seeking PGD on a case-by-case basis, as is the case in Spain. Rather, the legal tests should serve 
as one of several bases for the general guidelines suggested by private, physician-led 
organizations that medical providers are expected to follow. Along with other content that the 
physician-led organization deems appropriate, the legal standard generally set out by courts to 
guide physician practice should be incorporated into these guidelines. 
The best-interests standard already has a footing in American jurisprudence. For 
example, in Curran v. Bosze, the Illinois Supreme Court laid out an easily applied test to 
determine when an organ or tissue transplant would be in a donor child’s best-interest. The 
procedure will be considered in the best interest of the donor child if: 
(1) the parent or guardian who consented on behalf of the minor was 
well informed of the risks and benefits to the child-donor inherent 
in the medical procedure; (2) the parent or guardian would be able 
to provide adequate emotional support to the donor; and (3) there 
was an existing, close relationship between the donor and 
recipient.161 
 
Aspects of the Curran best-interest test should be incorporated into guidelines 
promulgated by physician professional organizations. The ASRM should assert that clinics are to 
perform PGD in order to create savior siblings must consider the parent or guardian’s ability to 
provide adequate emotional support to the donor such that the donor child will be well-provided 
for if created. Additionally, parents of a potential donor child should be able to understand the 
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risks and benefits to a potential donor-child. If a parent cannot sufficiently articulate an 
understanding of the effects on the well-being of a potential child, they should not be able to use 
PGD to create a savior sibling. The guidelines will serve to steer clinics towards the right result 
ethically and legally. 
D. Reporting Requirements 
The ASRM may be the superior vehicle to promulgate guidelines regarding savior 
siblings even after the PGD process is complete because of the organization’s ability to mandate 
reporting requirements when a clinic undergoes PGD for the purpose of creating a savior sibling. 
The data collected by the ASRM and any follow-up data that clinics collect regarding the well-
being of the donor-child and family can by synthesized into one database controlled by the 
ASRM, or a similar organization. This data could be used to further refine the ASRM guidelines 
and any guidelines promulgated by other medical professional organizations regarding the well-
being of donor-siblings. 
In sum, a private organization like the ASRM could follow the government-led models in 
the UK and France when deciding how to regulate PGD for the use of savior siblings. The 
ASRM could lay out appropriate uses of PGD, including savior siblings, and lay down standards 
under which clinics could evaluate a specific case. These standards should fold in the legal 
standards as a guide for the behavior of clinicians providing PGD. These physician-promulgated 
guidelines will eventually become the baseline standard-of-care and any clinic that fails to follow 
these guidelines would face criticism and potential litigation. 
Conclusion 
“Parents may be free to become martyrs themselves. But it does not follow that they are 
free, in identical circumstances, to make martyrs of their children before they have reached the 
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age of full and legal discretion when they can make that choice for themselves.”162 Judge 
Steinfeld wrote these words in 1969, unaware of the vast potential of artificial reproductive 
technology. The decades since Judge Steinfeld’s dissenting opinion have brought unprecedented 
growth in artificial reproductive technology. With regard to a minor child’s ability to consent to 
medical procedures, the question American society now faces is: are we going to allow parents 
and clinicians to have unfettered discretion to determine under what circumstances a child should 
be created for the purpose of healing an ailing older sibling? 
 I argue that because of the potential ethical pitfalls, regulators should cabin parents’ and 
clinicians’ unfettered discretion in order to account for the best interests of the family and the 
potential donor-child. Given substantial political obstacles, the most effective way to enact these 
regulations is privately, through professional physician organizations. Organizations like the 
ASRM can work off of the structure of already-existing regulatory bodies in Europe to determine 
how to promulgate guidelines regarding the use of PGD to create savior siblings. Further, these 
organizations should enact guidelines that advance the best interests of a minor donor-child, and 
account for the informed consent of a minor child who is able to provide such consent. The 
private organization that takes on the task of promulgating guidelines regarding the use of PGD 
for savior siblings should also keep a robust data set that tracks the well-being of donor-children 
over many years. 
 Private self-regulation is a substantial first step to creating significant safeguards for 
potential donor-children. Regulation through professional medical organizations protects the 
autonomy of medical professionals and individuals while maintaining a careful consideration of 
the potential dangers to a donor-child. Since parents should not compel their children to be 
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martyrs for the sake of saving an already-existing older child, the medical profession must step in 
to ensure that all potential human interests are accounted for. 
 
 
